AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20581724 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 53
Study 20581724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 18076221 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (n = 24) - Stepwise periodized resistance exercise program + 100 swings/day, 3 days/week for 12 weeks
Number of subjects: 49
Study 18076221 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (n = 25) - Stepwise periodized resistance exercise program + additional rotational and full-body medicine ball exercises, 3 days/week for 12 weeks
Number of subjects: 49
Study 18076221 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 49
Study 16219016 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily gliclazide MR
Number of subjects: 105
Study 16219016 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily glibenclamide
Number of subjects: 105
Study 12169344 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon monoxide exposure
Number of subjects: 41
Study 12169344 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 12169344 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CO and control)
Number of subjects: 41
Study 9850444 — intervention group
Group type: EXPERIMENTAL
Intervention: Sang-35
Number of subjects: 122
Study 9850444 — intervention group
Group type: COMPARATOR
Intervention: Neoral
Number of subjects: 122
Study 9850444 — intervention group
Group type: COMPARATOR
Intervention: Sandimmune
Number of subjects: 122
Study 9850444 — intervention group
Group type: EXPERIMENTAL
Intervention: Sang-35 and Neoral
Number of subjects: 122
Study 7642660 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐intensity neuromuscular electrical stimulation (alone or combined with low‐intensity)
Number of subjects: 110
Study 7642660 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐level volitional exercise
Number of subjects: 110
Study 7642660 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐intensity neuromuscular electrical stimulation
Number of subjects: 110
Study 7642660 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined high and low‐intensity neuromuscular electrical stimulation
Number of subjects: 110
Study 7642660 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 110
Study 7642660 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with autologous patellar‐ligament graft
Number of subjects: 110
Study 2502074 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunfural S (new oral form)
Number of subjects: 101
Study 2502074 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunfural Rectal Capsules (new soft-capsule suppository form)
Number of subjects: 101
Study 2502074 — intervention group
Group type: COMPARATOR
Intervention: existing drugs
Number of subjects: 101
Study 284168 — intervention group
Group type: EXPERIMENTAL
Intervention: vincristine, prednisone and daunorubicin (VPD)
Number of subjects: 56
Study 284168 — intervention group
Group type: EXPERIMENTAL
Intervention: vincristine, prednisone and adriamycin (VPA)
Number of subjects: 56
Study 284168 — intervention group
Group type: COMPARATOR
Intervention: vincristine and prednisone (VP)
Number of subjects: 56
Study 30359764 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-emptive analgesia with paracetamol (P), ketorolac (K), and pregabalin (PR) administered 4 hours before surgery
Number of subjects: 100
Study 30359764 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 100
Study 26725194 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 000 IU of Vitamin A
Number of subjects: 210
Study 26725194 — intervention group
Group type: COMPARATOR
Intervention: 200 000 IU of Vitamin A
Number of subjects: 210
Study 25885548 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention with a neurotrophic dietary supplement
Number of subjects: 120
Study 25885548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 22946523 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor stress
Number of subjects: 2
Study 21440951 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib treatment
Number of subjects: 106
Study 21440951 — intervention group
Group type: COMPARATOR
Intervention: IGFBP-3
Number of subjects: 106
Study 19744717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azithromycin (6 biannual mass treatments)
Number of subjects: 758
Study 17693688 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate‐electrolyte solution (CES)
Number of subjects: 9
Study 17693688 — intervention group
Group type: COMPARATOR
Intervention: Flavored water (FW)
Number of subjects: 9
Study 15551195 — intervention group
Group type: EXPERIMENTAL
Intervention: mCPP infusion (serotonin agonist)
Number of subjects: 32
Study 15551195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 11404667 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric chainring
Number of subjects: 11
Study 11404667 — intervention group
Group type: COMPARATOR
Intervention: Round chainring
Number of subjects: 11
Study 9509175 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal splenic aspiration
Number of subjects: 270
Study 9509175 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal splenic aspiration
Number of subjects: 270
Study 9509175 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow aspiration
Number of subjects: 270
Study 8364139 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone for 4 weeks followed by thrice weekly lymphoblastoid alpha-interferon for 12 weeks
Number of subjects: 18
Study 8364139 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 18
Study 3745731 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of d‐amphetamine
Number of subjects: 44
Study 3745731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 29160118 — intervention group
Group type: EXPERIMENTAL
Intervention: Cracking the Code (CtC) program
Number of subjects: 0
Study 29160118 — intervention group
Group type: COMPARATOR
Intervention: Alternative program targeting semantics and grammar (Control)
Number of subjects: 0
Study 30008422 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV16 E2 gene variations in cervical cancer patients
Number of subjects: 251
Study 30008422 — intervention group
Group type: EXPERIMENTAL
Intervention: T3575G (S274A) variation in the EUR variant
Number of subjects: 251
Study 30008422 — intervention group
Group type: COMPARATOR
Intervention: As variant frequency
Number of subjects: 251
Study 27931208 — intervention group
Group type: EXPERIMENTAL
Intervention: MPCNL using patented suctioning sheath
Number of subjects: 182
Study 27931208 — intervention group
Group type: COMPARATOR
Intervention: MPCNL traditionally using peel-away sheath
Number of subjects: 182
Study 24621122 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation containing 10 mg lutein, 10 mg meso-zeaxanthin, and 2 mg zeaxanthin (Trial 1)
Number of subjects: 135
Study 24621122 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation containing 10 mg lutein, 10 mg meso-zeaxanthin, 2 mg zeaxanthin, 500 mg vitamin C, 400 IU vitamin E, 25 mg zinc, and 2 mg copper (Intervention A; Trial 2)
Number of subjects: 135
Study 24621122 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation containing 10 mg lutein and 2 mg zeaxanthin, 500 mg vitamin C, 400 IU vitamin E, 25 mg zinc, and 2 mg copper (Intervention B; Trial 2)
Number of subjects: 135
Study 24621122 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Trial 1)
Number of subjects: 135
Study 24621122 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 135
Study 22249647 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous landiolol (5 μg/kg/min) followed by oral carvedilol (2.5-5 mg/day)
Number of subjects: 70
Study 22249647 — intervention group
Group type: COMPARATOR
Intervention: Oral carvedilol (2.5-5 mg/day) alone
Number of subjects: 70
Study 19200989 — intervention group
Group type: EXPERIMENTAL
Intervention: CDB‐2914 (10, 50, or 100 mg)
Number of subjects: 56
Study 19200989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 17405895 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (15 g twice a day for seven consecutive days every 2 weeks starting on the day of oxaliplatin infusion)
Number of subjects: 86
Study 17405895 — intervention group
Group type: COMPARATOR
Intervention: Control (no glutamine)
Number of subjects: 86
Study 16291369 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone cream applied to the distal aspect of the prepuce twice daily for the first 15 days, then once daily for 15 more days, combined with preputial gymnastics starting 1 week after topical application.
Number of subjects: 247
Study 16291369 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 247
Study 12742207 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchful waiting
Number of subjects: 637
Study 12742207 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein tension‐free hernia repair (operation)
Number of subjects: 637
Study 10800627 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened Spanish version of the Conners Parents Rating Scale (CPRS)
Number of subjects: 540
Study 10800627 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened Spanish version of the Conners Teacher Rating Scale (CTRS)
Number of subjects: 540
Study 8648305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented acetabular components
Number of subjects: 224
Study 8648305 — intervention group
Group type: COMPARATOR
Intervention: Cementless acetabular components
Number of subjects: 224
Study 1335221 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (four logarithmically increasing doses)
Number of subjects: 36
Study 1335221 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam
Number of subjects: 36
Study 1335221 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched volumes)
Number of subjects: 36
Study 6383139 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium chloride
Number of subjects: 32
Study 6383139 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 32
Study 2935608 — intervention group
Group type: EXPERIMENTAL
Intervention: Angelchik prosthesis
Number of subjects: 47
Study 2935608 — intervention group
Group type: COMPARATOR
Intervention: Nissen fundoplication
Number of subjects: 47
Study 30502026 — intervention group
Group type: EXPERIMENTAL
Intervention: External Rotation (ER)
Number of subjects: 50
Study 30502026 — intervention group
Group type: COMPARATOR
Intervention: Internal Rotation (IR)
Number of subjects: 50
Study 30502026 — intervention group
Group type: EXPERIMENTAL
Intervention: Healed Labrum (regardless of immobilization)
Number of subjects: 50
Study 30502026 — intervention group
Group type: COMPARATOR
Intervention: Non-Healed Labrum (regardless of immobilization)
Number of subjects: 50
Study 31234791 — intervention group
Group type: EXPERIMENTAL
Intervention: RABWSTT with EMG biofeedback system
Number of subjects: 16
Study 28418482 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg, single oral dose)
Number of subjects: 576
Study 28418482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study 25613634 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Houxue Bushen Decoction (treatment group)
Number of subjects: 120
Study 25613634 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy (control group)
Number of subjects: 120
Study 23447479 — intervention group
Group type: COMPARATOR
Intervention: Rituximab (500 mg or 1000 mg for 1 or 2 cycles) for 24 weeks
Number of subjects: 100
Study 23447479 — intervention group
Group type: COMPARATOR
Intervention: Rituximab (500 mg or 1000 mg for 2 cycles) for 48 weeks
Number of subjects: 100
Study 23447479 — intervention group
Group type: COMPARATOR
Intervention: Control (Methotrexate)
Number of subjects: 100
Study 21757673 — intervention group
Group type: EXPERIMENTAL
Intervention: Montreal Cognitive Assessment (MoCA) administered at 3 months post-stroke.
Number of subjects: 294
Study 21757673 — intervention group
Group type: EXPERIMENTAL
Intervention: MoCA completion rates by stroke severity: 87% with mild stroke, 79% with moderate stroke, and 67% with severe stroke.
Number of subjects: 294
Study 18287122 — intervention group
Group type: EXPERIMENTAL
Intervention: Music group
Number of subjects: 60
Study 18287122 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 17156466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-pregnancy intervention provided by midwives, including discussions on social, health or lifestyle problems, preparation and timing for pregnancy, family history, rubella immunisation, referrals for health problems, and a reminder card.
Number of subjects: 0
Study 17156466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-pregnancy intervention
Number of subjects: 0
Study 17156466 — intervention group
Group type: COMPARATOR
Intervention: Standard care (comparison group)
Number of subjects: 0
Study 14571006 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki-like healing practices
Number of subjects: 0
Study 11113620 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% alcohol administered intravenously (IV)
Number of subjects: 6
Study 11113620 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously (IV)
Number of subjects: 6
Study 8938179 — intervention group
Group type: EXPERIMENTAL
Intervention: ELAD haemoperfusion
Number of subjects: 24
Study 8938179 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 8938179 — intervention group
Group type: EXPERIMENTAL
Intervention: ELAD haemoperfusion (Group I)
Number of subjects: 24
Study 8938179 — intervention group
Group type: COMPARATOR
Intervention: Control (Group I)
Number of subjects: 24
Study 8938179 — intervention group
Group type: EXPERIMENTAL
Intervention: ELAD haemoperfusion (Group II)
Number of subjects: 24
Study 8938179 — intervention group
Group type: COMPARATOR
Intervention: Control (Group II)
Number of subjects: 24
Study 1403845 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucin containing chewing gum
Number of subjects: 43
Study 1403845 — intervention group
Group type: EXPERIMENTAL
Intervention: V6
Number of subjects: 43
Study 1403845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 1403845 — intervention group
Group type: EXPERIMENTAL
Intervention: All products (Mucin chewing gum, V6, Placebo)
Number of subjects: 43
Study 3886207 — intervention group
Group type: COMPARATOR
Intervention: CU 32-085 (0.5 mg single dose)
Number of subjects: 12
Study 3886207 — intervention group
Group type: EXPERIMENTAL
Intervention: CU 32-085 (8 mg daily for 3 months)
Number of subjects: 12
Study 3886207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31886909 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM-C
Number of subjects: 65
Study 31886909 — intervention group
Group type: COMPARATOR
Intervention: DBBM
Number of subjects: 65
Study 30264692 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU)
Number of subjects: 80
Study 30264692 — intervention group
Group type: COMPARATOR
Intervention: Radical prostatectomy (RP)
Number of subjects: 80
Study 30264692 — intervention group
Group type: EXPERIMENTAL
Intervention: QuinteT Recruitment Intervention (QRI)
Number of subjects: 80
Study 30264692 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcome measures (PROMs)
Number of subjects: 80
Study 30264692 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical case report forms (CRFs)
Number of subjects: 80
Study 27766408 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee in flexion with deflated tourniquet
Number of subjects: 120
Study 27766408 — intervention group
Group type: COMPARATOR
Intervention: Knee in extension with inflated tourniquet
Number of subjects: 120
Study 27766408 — intervention group
Group type: COMPARATOR
Intervention: Knee in extension with deflated tourniquet
Number of subjects: 120
Study 27766408 — intervention group
Group type: COMPARATOR
Intervention: Knee in flexion with inflated tourniquet
Number of subjects: 120
Study 24879552 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave therapy (1500 shots/muscle, frequency of 5Hz, energy of 0.030 mJ/mm, one session/week)
Number of subjects: 30
Study 24879552 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy exercise program for 3 months
Number of subjects: 30
Study 24879552 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave therapy
Number of subjects: 30
Study 24879552 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy exercise program
Number of subjects: 30
Study 22579071 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-20 mg/day)
Number of subjects: 50
Study 20195742 — intervention group
Group type: EXPERIMENTAL
Intervention: Early behavioral adherence (diet, self-monitoring, attendance)
Number of subjects: 0
Study 20195742 — intervention group
Group type: EXPERIMENTAL
Intervention: Early dietary adherence
Number of subjects: 0
Study 20195742 — intervention group
Group type: EXPERIMENTAL
Intervention: Early behavioral adherence
Number of subjects: 0
Study 18594050 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (2 weeks treatment)
Number of subjects: 31
Study 18594050 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (6 months treatment)
Number of subjects: 31
Study 16015135 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxic training (60% O2)
Number of subjects: 9
Study 16015135 — intervention group
Group type: COMPARATOR
Intervention: Normoxic training (21% O2)
Number of subjects: 9
Study 16015135 — intervention group
Group type: EXPERIMENTAL
Intervention: Both H and N training
Number of subjects: 9
Study 16015135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory response at 80% VO2max
Number of subjects: 9
Study 12665405 — intervention group
Group type: EXPERIMENTAL
Intervention: Long bout of exercise (LBE group, n=51)
Number of subjects: 143
Study 12665405 — intervention group
Group type: EXPERIMENTAL
Intervention: Short bouts of exercise (SBE group, n=56)
Number of subjects: 143
Study 12665405 — intervention group
Group type: COMPARATOR
Intervention: No exercise (NE group, n=36)
Number of subjects: 143
Study 10189126 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent 5-fluorouracil (5-FU) and mitomycin-C
Number of subjects: 64
Study 10189126 — intervention group
Group type: COMPARATOR
Intervention: Concurrent 5-fluorouracil (5-FU)
Number of subjects: 64
Study 7485297 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available dinoprostone gel 0.5 mg
Number of subjects: 134
Study 7485297 — intervention group
Group type: COMPARATOR
Intervention: Hospital-compounded formulation of 0.5 mg of prostaglandin E2 gel
Number of subjects: 134
Study 2218419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 200 mg b.i.d. for seven days
Number of subjects: 188
Study 2218419 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin 500 mg b.i.d. for seven days
Number of subjects: 188
Study 505427 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile elastic stockings worn for up to 17 days or until patient discharge
Number of subjects: 61
Study 505427 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stockings)
Number of subjects: 61
Study 31830304 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33°C for 24 hours
Number of subjects: 338
Study 31830304 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33°C for 48 hours
Number of subjects: 338
Study 31830304 — intervention group
Group type: COMPARATOR
Intervention: Comparison of H/I ratio between survivors and non-survivors
Number of subjects: 338
Study 31477061 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard model of family psychoeducation (SM-FPE) plus treatment as usual (TAU)
Number of subjects: 74
Study 31477061 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 74
Study 30148718 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab (OMA) as add-on to allergen-specific immunotherapy (AIT)
Number of subjects: 0
Study 30148718 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study 26867542 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing acute noninvasive ventilation as a long-term therapy
Number of subjects: 150
Study 26867542 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 24355200 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 456
Study 24355200 — intervention group
Group type: COMPARATOR
Intervention: IFG compared to normoglycaemia
Number of subjects: 456
Study 23413719 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-theoretical Model-based planned education
Number of subjects: 60
Study 18331737 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat, Western meal (HIFAT)
Number of subjects: 15
Study 18331737 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber meal (HIFIB)
Number of subjects: 15
Study 18331737 — intervention group
Group type: EXPERIMENTAL
Intervention: Both meals
Number of subjects: 15
Study 17229242 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 104
Study 17229242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 14962154 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid reimbursement rate increase of $10 above the mean rate of approximately $75
Number of subjects: 2080
Study 11377645 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta‐1a 22 microg subcutaneously once weekly for 2 years
Number of subjects: 308
Study 11377645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 9555794 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidified nitrite cream (3% salicylic acid in aqueous cream and 3% nitrite in aqueous cream) applied twice daily for 4 weeks
Number of subjects: 60
Study 9555794 — intervention group
Group type: COMPARATOR
Intervention: Control group (3% salicylic acid in aqueous cream and aqueous cream alone)
Number of subjects: 60
Study 9555794 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidified nitrite cream (3% salicylic acid in aqueous cream and 3% nitrite in aqueous cream)
Number of subjects: 60